The U937 cell line was seeded at 2 x 10⁵ cells per well. by Janani Madhuravasal Krishnan (19736002)

The total muscle and motor unit capacities for initial target forces of 15, 50 and 85% until total muscle capacity decreased to 15% MVC (ie. 85% muscle fatigue for each trial). by Jim R. Potvin (4062412)

Smoothed density histograms of simulated cumulative RCS exposures of increasing mean values. by Patrick Howlett (2612374)

Subjects:

SAA in a 50 year-old woman with HHT and severe liver involvement. by Jacques Sellier (8351355)

Statistical evaluation of cerebral autoregulation indices at different time points during the experiment: baseline, last LBNP/LBPP level (LBNP: first 10 seconds), presyncope (5 sec... by Marcus Thudium (6441863)

Shiga toxin expression in O157 following treatment with hGRNL, bNK2A, and pNKL peptides. by Erika N. Biernbaum (12647386)

Mean ± SD values for the parameters found when Eq. 8 (S1 Appendix) was used to model the relationship between time duration of movement (<i>t</i>_<i>dur</i>) and the weig... by Kai Roecker (847195)

Dynamic of prolactin in pregnant women during pregnancy. by Francois Kiemde (5369657)

“…For primigravidae, this concentration increase from V1 to V3 before decreasing at V4 and V5.</p>…”

High-throughput drug screen reveals HDAC and proteasome inhibitors as potent drug classes against synovial sarcoma. by Aimée N. Laporte (3617987)

“…(C) Compounds that brought about greater than 90% decreased relative cell viability were scored as 1 (+++), 75.1–90% as 0.5 (++), 50–75% as 0.25 (+) and less than 50% as 0 (-). …”

Statistical summary for weekly weather and air quality variables in state parks and protected areas (PPA) over the study period (2017 - 2021) in the Pacific Northwest, United State... by Kira Minehart (21029571)

Statistical summary for weekly weather and air quality variables in local parks and protected areas (PPA) over the study period (2017 - 2021) in the Pacific Northwest, United State... by Kira Minehart (21029571)

Statistical summary for weekly weather and air quality variables in federal parks and protected areas (PPA) over the study period (2017 - 2021) in the Pacific Northwest, United Sta... by Kira Minehart (21029571)

S1 Data - by Francois Kiemde (5369657)

“…Venous blood was collected at scheduled visit: Visit 1 (V1; 16–20 weeks of amenorrhea), Visit 2 (V2; 28 ±1 weeks of pregnancy), Visit 3 (V3; 32 ±1 weeks of pregnancy), Visit4 (V4; delivery) and Visit5 (V5; 6–7 weeks after delivery). …”

Characteristic of study population. by Francois Kiemde (5369657)

“…Venous blood was collected at scheduled visit: Visit 1 (V1; 16–20 weeks of amenorrhea), Visit 2 (V2; 28 ±1 weeks of pregnancy), Visit 3 (V3; 32 ±1 weeks of pregnancy), Visit4 (V4; delivery) and Visit5 (V5; 6–7 weeks after delivery). …”

Decreased expression of 5-HT_2A receptors but not of PSD-95 in spinal cord of carrageenan-injected rats. by Anne-Sophie Wattiez (460341)

Decreased <i>S</i>. <i>epidermidis</i> biofilm formation on immobilized proteins MBP-QQ-5 and MBP-QQ-7. by Nancy Weiland-Bräuer (5581526)

Deletion <i>of bipA</i> in <i>E. coli</i> and <i>S.</i> Typhimurium results in a growth defect at low temperatures. by Eunsil Choi (8271039)

Influence of mean daily temperature (MDT) and daily light integral (DLI) on purple basil ‘Dark Opal’ (<i>Ocimum basilicum</i>). by Kellie J. Walters (10451329)

Subjects:

Awareness of disabilities in pharmacy program recruitment material: are we doing enough? by Hussain, Farhat Naz

“…Introduction: Targeted recruitment of students with disabilities is a novel area in pharmacy education and may help to attract qualified students in light of decreasing applicant numbers. …”
Get full text
Get full text

Mean SARS-CoV-2 viral load log 10 between groups. by Bruno Martins Tomazini (6509528)

“…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”